Cocrystal Pharma, Inc.
COCP
$1.24
$0.065.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 105.00K | 225.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 105.00K | 225.00K | -- | -- | -- |
| Cost of Revenue | 2.14M | 1.37M | 1.62M | 954.00K | 1.12M |
| Gross Profit | -2.04M | -1.15M | -1.62M | -954.00K | -1.12M |
| SG&A Expenses | 1.15M | 1.21M | 862.00K | 1.14M | 986.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.29M | 2.58M | 2.48M | 2.09M | 2.11M |
| Operating Income | -3.18M | -2.36M | -2.48M | -2.09M | -2.11M |
| Income Before Tax | -3.16M | -2.30M | -2.43M | -2.05M | -2.06M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.16M | -2.30M | -2.43M | -2.05M | -2.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.16M | -2.30M | -2.43M | -2.05M | -2.06M |
| EBIT | -3.18M | -2.36M | -2.48M | -2.09M | -2.11M |
| EBITDA | -3.17M | -2.34M | -2.47M | -2.08M | -2.09M |
| EPS Basic | -0.23 | -0.17 | -0.18 | -0.19 | -0.20 |
| Normalized Basic EPS | -0.14 | -0.10 | -0.11 | -0.12 | -0.13 |
| EPS Diluted | -0.23 | -0.17 | -0.18 | -0.19 | -0.20 |
| Normalized Diluted EPS | -0.14 | -0.10 | -0.11 | -0.12 | -0.13 |
| Average Basic Shares Outstanding | 13.79M | 13.79M | 13.81M | 10.99M | 10.17M |
| Average Diluted Shares Outstanding | 13.79M | 13.79M | 13.81M | 10.99M | 10.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |